[1]
S. Liu, X. Wang, H. Gao, L. Ye, J. Tian, and G. Du, “Pharmacodynamics study of a new 5-HT₂ᴀ receptor inverse agonist PCC03039”, JPBR, vol. 3, no. 2, pp. 228-236, Mar. 2022.